Nontuberculous mycobacterial disease in solid-organ transplant recipients and the general population
Hosseini-Moghaddam SM, Fridman D, Drover SSM, Marras TK, Brode SK, Jamieson FB, Husain S, Kwong JC. JAMA Netw Open. 2025; 8(9):e2531563.
Publications
Gaps in immunization coverage at school entry and after two years of school attendance among immigrant and refugee children in Ontario, Canada
Wilson SE, Chambers C, Wilton AS, Bai L, Crowcroft N, Deeks SL, Halperin SA, Kwong JC, Rashid M, Tu K, Wilson K, Guttmann A. PLoS One. 2025; 20(9):e0330955.
Association between dipeptidyl peptidase-4 inhibitors and glucagon-like peptide-1 receptor agonists and COVID-19 infection and adverse outcomes: a cohort study
Thompson W, Yu B, Porter J, Fang J, Ferreira-Legere LE, Austin PC, Jackevicius CA, Ross H, Lee DS, Weisman A, Farkouh ME, Gershon AS, Atzema CL, Kwong JC, Ha A, Džavík V, Udell JA. BMJ Open Diabetes Res Care. 2025; 13(4):e004677.
Incidence of respiratory syncytial virus-associated hospitalization among adults in Ontario, Canada, 2017-2019
Buchan SA, Alessandrini J, Drover SSM, Andrew MK, Bronskill SE, Brown KA, Daneman N, Deeks SL, Gubbay JB, Johnstone J, Karnauchow TM, Lee S, McGeer AJ, McNally JD, McNeil SA, Mubareka S, Murti M, Smieja M, Wilson SE, Kwong JC. J Infect Dis. 2025; jiaf343. Epub 2025 Jul 30.
Respiratory syncytial virus (RSV)-related hospitalization and increased rate of cardiovascular events in older adults
Verschoor CP, Cerasuolo JO, Caswell JM, Tatangelo M, Costa-Vitali A, Savage DW, Kwong JC. J Am Geriatr Soc. 2025 Jul 23.
Measles seroprevalence among individuals serologically tested in Ontario, Canada
Ariyarajah A, Crowcroft NS, Brown KA, Wang J, Kwong JC, Bolotin S. Vaccine. 2025; 62:127446. Epub 2025 Jul 11.
COVID-19 vaccine uptake in a retrospective population-based cohort of people living with and without HIV in Ontario, Canada
Freitas C, Cooper CL, Kroch AE, Moineddin R, Arbess G, Benoit AC, Buchan SA, Chambers C, Habanyama M, Kendall CE, Kwong JC, Mbuagbaw L, McCullagh J, Moqueet N, Nambiar D, Rueda S, Tran V, Walmsley S, Burchell AN; CHESS Study Team. Vaccine. 2025; 61:127422. Epub 2025 Jul 1.
Risk of Guillain-Barré syndrome after COVID-19 vaccination or SARS-CoV-2 infection: a multinational self-controlled case series study
Nasreen S, Jiang Y, Lu H, Lee A, Cutland CL, Gentile A, Giglio N, Macartney K, Deng L, Liu B, Sonneveld N, Bellamy K, Clothier HJ, Sepulveda Kattan G, Naus M, Naveed Z, Janjua NZ, Nguyen L, Hviid A, Poukka E, Perälä J, Leino T, Chandra LA, Thobari JA, Park BJ, Choi NK, Jeong NY, Madhi SA, Villalobos F, Solórzano M, Bissacco CA, Carreras-Martínez JJ, Correcher-Martínez E, Urchueguía-Fornes A, Roy D, Yeomans A, Aurelius T, Morton K, Di Mauro G, Sturkenboom MC, Sejvar JJ, Top KA, Batty K, Ghebreab L, Griffin JB, Petousis-Harris H, Buttery J, Black S, Kwong JC. Vaccine. 2025 May 28;60:127291. [Epub ahead of print].
Limited durability of protection conferred by XBB.1.5 vaccines against omicron-associated severe outcomes among community-dwelling adults, Ontario, Canada
Lee N, Nguyen L, Nasreen S, Austin PC, Brown KA, Buchan SA, Grewal R, Schwartz KL, Tadrous M, Wilson K, Wilson SE, Kwong JC; Canadian Immunization Research Network (CIRN) Investigators. Vaccine. 2025; May 26 [Epub ahead of print].
Validation of influenza vaccination status using health administrative databases by integrating pharmacy claims and medical billing databases in Ontario, Canada
Amoud R, Kwong JC, Maxwell C, Tyas SL, Cooke M, Hernandez A, Alsabbagh W. BMC Infect Dis. 2025 May 4;25(1):653.